Ontology highlight
ABSTRACT:
SUBMITTER: Sihn CR
PROVIDER: S-EPMC8749450 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
Sihn Choong-Ryoul CR Handyside Britta B Liu Su S Zhang Lening L Murphy Ryan R Yates Bridget B Xie Lin L Torres Richard R Russell Chris B CB O'Neill Charles A CA Pungor Erno E Bunting Stuart S Fong Sylvia S
Molecular therapy. Methods & clinical development 20211221
Valoctocogene roxaparvovec (AAV5-hFVIII-SQ) is an adeno-associated virus serotype 5 (AAV5)-based gene therapy vector containing a B-domain-deleted human coagulation factor VIII (hFVIII) gene controlled by a liver-selective promoter. AAV5-hFVIII-SQ is currently under clinical investigation as a treatment for severe hemophilia A. The full-length AAV5-hFVIII-SQ is >4.9 kb, which is over the optimal packaging limit of AAV5. Following administration, the vector must undergo a number of genome-process ...[more]